LABA and LAMA are used to relieve the symptoms of bronchoconstriction, whereas ICS serve to reduce the airway inflammation. Currently, Spiriva (tiotropium bromide; Pfizer/Boehringer Ingelheim ...
LAMA are potent and first-line bronchodilators in COPD but generally take longer to have effect than their LABA bronchodilator counterparts. Tiotropium and aclidinium are currently available for ...
The impact of the addition of tiotropium (Tio) to ICS + LABA therapy on all-cause mortality, hospital admissions for respiratory disease, and emergency oral corticosteroid bursts was evaluated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback